Extracellular Vesicles Containing IL-4 Modulate Neuroinflammation in a Mouse Model of Multiple Sclerosis
Autor: | Paola Podini, Gerard Ill-Raga, Mattia Bastoni, Gianvito Martino, Giacomo Casella, Federico Colombo, Annamaria Finardi, Luca Muzio, Hélène Descamps, Antonello E. Spinelli, Roberto Furlan |
---|---|
Přispěvatelé: | Casella, Giacomo, Colombo, Federico, Finardi, Annamaria, Descamps, Hélène, Ill-Raga, Gerard, Spinelli, Antonello, Podini, Paola, Bastoni, Mattia, Martino, Gianvito, Muzio, Luca, Furlan, Roberto |
Jazyk: | angličtina |
Rok vydání: | 2018 |
Předmět: |
0301 basic medicine
CD4-Positive T-Lymphocytes Multiple Sclerosis medicine.medical_treatment Cell Line neuroinflammation 03 medical and health sciences Extracellular Vesicles Mice Downregulation and upregulation Microscopy Electron Transmission Genetic Drug Discovery Genetics medicine Animals Molecular Biology Neuroinflammation Interleukin 4 Cells Cultured Lactadherin Pharmacology CD11b Antigen Microglia Chemistry Reverse Transcriptase Polymerase Chain Reaction Macrophages Drug Discovery3003 Pharmaceutical Science Experimental autoimmune encephalomyelitis phagocyte medicine.disease Cell biology Rats Mice Inbred C57BL Disease Models Animal 030104 developmental biology medicine.anatomical_structure Cytokine Microscopy Fluorescence Drug delivery Molecular Medicine Female Original Article Interleukin-4 extracellular vesicle |
Popis: | Extracellular vesicles (EVs) play a major role in cell-to-cell communication in physiological and pathological conditions, and their manipulation may represent a promising therapeutic strategy. Microglia, the parenchymal mononuclear phagocytes of the brain, modulate neighboring cells also through the release of EVs. The production of custom EVs filled with desired molecules, possibly targeted to make their uptake cell specific, and their administration in biological fluids may represent a valid approach for drug delivery. We engineered a murine microglia cell line, BV-2, to release EVs overexpressing the endogenous “eat me” signal Lactadherin (Mfg-e8) on the surface to target phagocytes and containing the anti-inflammatory cytokine IL-4. A single injection of 107 IL-4+Mfg-e8+ EVs into the cisterna magna modulated established neuroinflammation and significantly reduced clinical signs in the mouse model of multiple sclerosis, experimental autoimmune encephalomyelitis (EAE). Injected IL-4+Mfg-e8+ EVs target mainly phagocytes (i.e., macrophages and microglia) surrounding liquoral spaces, and their cargo promote the upregulation of anti-inflammatory markers chitinase 3-like 3 (ym1) and arginase-1 (arg1), significantly reducing tissue damage. Engineered EVs may represent a biological drug delivery tool able to deliver multiple functional molecules simultaneously to treat neuroinflammatory diseases. Extracellular vesicles (EVs) are a physiological way of intercellular communication. We show here that it is possible to deliver EVs engineered to contain different molecules for therapeutic purposes. Using this strategy, we have successfully delivered an anti-inflammatory cytokine to treat a mouse model of multiple sclerosis. |
Databáze: | OpenAIRE |
Externí odkaz: |